Surfactant therapy for meconium aspiration syndrome: Current status

Drugs

Volumn 65, Issue 18, 2005, Pages 2569-2591

  Dargaville, Peter A ^a,b   Mills, John F ^c  

^a ROYAL HOBART HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BERACTANT; BLES; CALFACTANT; DIPALMITOYLPHOSPHATIDYLCHOLINE; LUCINACTANT; LUSUPULTIDE; PHOSPHOLIPID; PORACTANT; PUMACTANT; SURFACTANT; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D; SURFACTANT TA;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTERIAL OXYGEN SATURATION; ARTIFICIAL VENTILATION; ASPIRATION PNEUMONIA; CLINICAL FEATURE; CLINICAL TRIAL; CYSTIC FIBROSIS; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; EXTRACORPOREAL OXYGENATION; HUMAN; HYALINE MEMBRANE DISEASE; INTUBATION; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS PROTEINOSIS; LUNG FUNCTION; LUNG GAS EXCHANGE; LUNG INJURY; LUNG LAVAGE; LUNG MECHANICS; LUNG VENTILATION; MECONIUM ASPIRATION; NONHUMAN; OXYGENATION; PATHOGENESIS; PATHOPHYSIOLOGY; PNEUMOTHORAX; PULMONARY HYPERTENSION; RESPIRATORY ACIDOSIS; REVIEW;

ANIMALS; BRONCHOALVEOLAR LAVAGE; HUMANS; INFANT, NEWBORN; MECONIUM ASPIRATION SYNDROME; PULMONARY SURFACTANTS; RANDOMIZED CONTROLLED TRIALS; RESPIRATION, ARTIFICIAL;

ANIMALIA;

EID: 30044436098     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200565180-00003     Document Type: Review

References (144)

1. Cleary GM, Wiswell TE. Meconium-stained amniotic fluid and the meconium aspiration syndrome: an update. Pediatr Clin North Am 1998; 45: 511-29
2. Greenough A. Meconium aspiration syndrome: prevention and treatment. Early Hum Dev 1995; 41: 183-92
3. Roberton NRC. Aspiration syndromes. In: Greenough A, Roberton NRC, Milner AD, editors. Neonatal respiratory disorders. London: Arnold, 1996: 313-33
4. Wiswell TE, Bent RC. Meconium staining and the meconium aspiration syndrome: unresolved issues. Pediatr Clin North Am 1993; 40: 955-81
5. Bacsik RD. Meconium aspiration syndrome. Pediatr Clin North Am 1977; 24: 463-79
6. Kamlin O, Dargaville PA, for the Australia and New Zealand Neonatal Network. The epidemiology of meconium aspiration syndrome [abstract]. 6th Annual Scientific Conference of the Perinatal Society of Australia and New Zealand; 2002 Mar 9-13; Christchurch
7. Rossi EM, Philipson EH, Williams TG, et al. Meconium aspiration syndrome: intrapartum and neonatal attributes. Am J Obstet Gynecol 1989; 161: 1106-10
8. Sriram S, Wall SN, Khoshnood B, et al. Racial disparity in meconium-stained amniotic fluid and meconium aspiration syndrome in the United States, 1989-2000. Obstet Gynecol 2003; 102: 1262-8
9. Adhikari M, Gouws E. Meconium aspiration in South Africa. S Afr Med J 1995; 85: 891-3
10. Ellison V, Lui K, Dargaville PA. Aspiration of bile as a cause of respiratory distress in the newborn infant. J Pediatr 2004; 144: 389-90
11. Gordon E, South M, McDougall PN, et al. Blood aspiration syndrome as a cause of respiratory distress in the newborn infant. J Pediatr 2003; 142: 200-2
12. Yeh TF, Harris V, Srinivasan G, et al. Roentgenographic findings in infants with meconium aspiration syndrome. JAMA 1979; 242: 60-3
13. Yuksel B, Greenough A, Gamsu HR. Neonatal meconium aspiration syndrome and respiratory morbidity during infancy. Pediatr Pulmonol 1993; 16: 358-61
14. Rubin BK, Tomkiewicz RP, Patrinos ME, et al. The surface and transport properties of meconium and reconstituted meconium solutions. Pediatr Res 1996; 40: 834-8
15. Higgins ST, Wu AM, Sen N, et al. Meconium increases surfactant secretion in isolated rat alveolar type II cells. Pediatr Res 1996; 39: 443-7
16. Oelberg DG, Downey SA, Flynn MM. Bile salt-induced intracellular Ca++ accumulation in type II pneumocytes. Lung 1990; 168: 297-308
17. de Beaufort AJ, Pelikan DM, Elferink JG, et al. Effect of interleukin 8 in meconium on in-vitro neutrophil chemotaxis. Lancet 1998; 352: 102-5
18. Altshuler G, Hyde S. Meconium-induced vasocontraction: a potential cause of cerebral and other fetal hypoperfusion and of poor pregnancy outcome. J Child Neurol 1989; 4: 137-42
19. Holopainen R, Soukka H, Halkola L, et al. Meconium aspiration induces a concentration-dependent pulmonary hypertensive response in newborn piglets. Pediatr Pulmonol 1998; 25: 107-13
20. Yeh TF, Lilien LD, Barathi A, et al. Lung volume, dynamic lung compliance, and blood gases during the first 3 days of postnatal life in infants with meconium aspiration syndrome. Crit Care Med 1982; 10: 588-92
21. Goerke J, Clements JA. Alveolar surface tension and lung surfactant. In: Macklem PT, Mead J, editors. Handbook of physiology, section 3: the respiratory system. Bethesda (MD): American Physiological Society, 1986: 247-61
22. Jobe AH. Pathophysiology of respiratory distress syndrome and surfactant metabolism. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology. 2nd ed. Philadelphia (PA): W.B. Saunders, 1998: 1299-314
23. Whitsett JA. Composition of pulmonary surfactant lipids and proteins. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology. 2nd ed. Philadelphia (PA): W.B. Saunders, 1998: 1251-9
24. Wright JR, Clements JA. Metabolism and turnover of lung surfactant. Am Rev Respir Dis 1987; 136: 426-44
25. Jobe AH, Ikegami M, Jacobs HC, et al. Surfactant pool sizes and severity of respiratory distress syndrome in prematurely delivered lambs. Am Rev Respir Dis 1983; 127: 751-5
26. Hallman M, Merritt TA, Akino T, et al. Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid: correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants. Am Rev Respir Dis 1991; 144: 1376-84
27. Chida S, Phelps DS, Cordle C, et al. Surfactant-associated proteins in tracheal aspirates of infants with respiratory distress syndrome after surfactant therapy. Am Rev Respir Dis 1988; 137: 943-7
28. Ballard PL, Merrill JD, Godinez RI, et al. Surfactant protein profile of pulmonary surfactant in premature infants. Am J Respir Crit Care Med 2003; 168: 1123-8
29. Jobe AH. Pulmonary surfactant therapy. N Engl J Med 1993; 328: 861-8
30. Suresh GK, Soll RF. Current surfactant use in premature infants. Clin Perinatol 2001; 28: 671-94
31. Herting E, Rauprich P, Stichtenoth G, et al. Resistance of different surfactant preparations to inactivation by meconium. Pediatr Res 2001; 50: 44-9
32. Bernhard W, Mottaghian J, Gebert A, et al. Commercial versus native surfactants: surface activity, molecular components, and the effect of calcium. Am J Respir Crit Care Med 2000; 162: 1524-33
33. Seeger W, Grube C, Gunther A, et al. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 1993; 6: 971-7
34. Curosurf® (poractant alfra) intratracheal suspension: NDA 20-744 [package insert]. Parma: Chiesi Farmaceutici, S.p.A., 2000
35. bLES Biochemicals Inc. Product description: bLes (bovine lipid extract surfactant). London (ONT): bLES Biochemicals Inc., 1994 Jun
36. Cummings JJ, Holm BA, Hudak ML, et al. A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs. Am Rev Respir Dis 1992; 145: 999-1004
37. Infasurf® [package insert]. St Louis (MO): Forest Pharmaceuticals, Inc., 2003 Jun
38. Willson D. Calfactant. Expert Opin Pharmacother 2001; 2: 1479-93
39. Exosurf® (colfosceril palmitate, cetyl alcohol, tyloxapol) neonatal for intratracheal suspension [package insert]. Research Triangle Park (NC): Burroughs Wellcome Co., 1990 Aug
40. Babu KS, Woodcock DA, Smith SE, et al. Inhaled synthetic surfactant abolishes the early allergen-induced response in asthma. Eur Respir J 2003; 21: 1046-9
41. Cleary GM, Antunes MJ, Ciesielka DA, et al. Exudative lung injury is associated with decreased levels of surfactant proteins in a rat model of meconium aspiration. Pediatrics 1997; 100: 998-1003
42. Davey AM, Becker JD, Davis JM. Meconium aspiration syndrome: physiological and inflammatory changes in a newborn piglet model. Pediatr Pulmonol 1993; 16: 101-8
43. Wiswell TE, Peabody SS, Davis JM, et al. Surfactant therapy and high-frequency jet ventilation in the management of a piglet model of the meconium aspiration syndrome. Pediatr Res 1994; 36: 494-500
44. Dargaville PA, Mills JF, Headley BM, et al. Therapeutic lung lavage in the piglet model of meconium aspiration syndrome. Am J Respir Crit Care Med 2003; 168: 456-63
45. Dargaville PA, South M, McDougall PN. Comparison of two methods of diagnostic lung lavage in ventilated infants with lung disease. Am J Respir Crit Care Med 1999; 160: 771-7
46. Bui KC, Walther FJ, David-Cu R, et al. Phospholipid and surfactant protein A concentrations in tracheal aspirates from infants requiring extracorporeal membrane oxygenation. J Pediatr 1992; 121: 271-4
47. Lotze A, Stroud CY, Soldin SJ. Serial lecithin/sphingomyelin ratios and surfactant/albumin ratios in tracheal aspirates from term infants with respiratory failure receiving extracorporeal membrane oxygenation. Clin Chem 1995; 41: 1182-8
48. Dargaville PA, South M, McDougall PN. Surfactant and surfactant inhibitors in meconium aspiration syndrome. J Pediatr 2001; 138: 113-5
49. Lotze A, Whitsett JA, Kammerman LA, et al. Surfactant protein A concentrations in tracheal aspirate fluid from infants requiring extracorporeal membrane oxygenation. J Pediatr 1990; 116: 435-40
50. Moses D, Holm BA, Spitale P, et al. Inhibition of pulmonary surfactant function by meconium. Am J Obstet Gynecol 1991; 164: 477-81
51. Sun B, Curstedt T, Robertson B. Surfactant inhibition in experimental meconium aspiration. Acta Paediatr 1993; 82: 182-9
52. Bae CW, Takahashi A, Chida S, et al. Morphology and function of pulmonary surfactant inhibited by meconium. Pediatr Res 1998; 44: 187-91
53. Clark DA, Nieman GF, Thompson JE, et al. Surfactant displacement by meconium free fatty acids: an alternative explanation for atelectasis in meconium aspiration syndrome. J Pediatr 1987; 110: 765-70
54. Terasaka D, Clark DA, Singh BN, et al. Free fatty acids of human meconium. Biol Neonate 1986; 50: 16-20
55. Sun B, Herting E, Curstedt T, et al. Exogenous surfactant improves lung compliance and oxygenation in adult rats with meconium aspiration. J Appl Physiol 1994; 77: 1961-71
56. Tyler DC, Murphy J, Cheney FW. Mechanical and chemical damage to lung tissue caused by meconium aspiration. Pediatrics 1978; 62: 454-9
57. Berger TM, Allred EN, Van Marter LJ. Antecedents of clinically significant pulmonary hemorrhage among newborn infants. J Perinatol 2000; 20: 295-300
58. Pandit PB, Dunn MS, Colucci EA. Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage. Pediatrics 1995; 95: 32-6
59. Fuchimukai T, Fujiwara T, Takahashi A, et al. Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol 1987; 62: 429-37
60. Ikegami M, Rebello CM, Jobe AH. Surfactant inhibition by plasma: gestational age and surfactant treatment effects in preterm lambs. J Appl Physiol 1996; 81: 2517-22
61. Lachmann B, Eijking EP, So KL, et al. In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function. Intensive Care Med 1994; 20: 6-11
62. Colacicco G, Basu MK. Effect of serum albumin on dynamic force-area curve of dipalmitoyl lecithin. Respir Physiol 1978; 32: 265-79
63. Holm BA, Notter RH, Finkelstein JN. Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids. Chem Phys Lipids 1985; 38: 287-98
64. Holm BA, Notter RH. Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity. J Appl Physiol 1987; 63: 1434-42
65. O'Brodovich HM, Weitz JI, Possmayer F. Effect of fibrinogen degradation products and lung ground substance on surfactant function. Biol Neonate 1990; 57: 325-33
66. Chen CT, Toung TJ, Rogers MC. Effect of intra-alveolar meconium on pulmonary surface tension properties. Crit Care Med 1985; 13: 233-6
67. Lu KW, William TH, Robertson B, et al. Polymer-surfactant treatment of meconium-induced acute lung injury. Am J Respir Crit Care Med 2000; 162: 623-8
68. Dargaville PA, Morley CJ. Overcoming surfactant inhibition with polymers. Acta Paediatr 2000; 89: 1397-400
69. Taeusch HW, Lu KW, Goerke J, et al. Nonionic polymers reverse inactivation of surfactant by meconium and other substances. Am J Respir Crit Care Med 1999; 159: 1391-5
70. Cochrane CG, Revak SD, Merritt TA, et al. Bronchoalveolar lavage with KL4-surfactant in models of meconium aspiration syndrome. Pediatr Res 1998; 44: 705-15
71. Bruni R, Fan BR, David-Cu R, et al. Inactivation of surfactant in rat lungs. Pediatr Res 1996; 39: 236-40
72. Seeger W, Gunther A, Thede C. Differential sensitivity to fibrinogen inhibition of SP-C- vs SP-B-based surfactants. Am J Physiol 1992; 262: L286-91
73. Almaas R, Robertson B, Linderholm B, et al. Reversal of meconium inhibition of pulmonary surfactant by ferric chloride, copper chloride, and acetic acid. Am J Respir Crit Care Med 2000; 162: 1789-94
74. Manalo E, Merritt TA, Kheiter A, et al. Comparative effects of some serum components and proteolytic products of fibrinogen on surface tension-lowering abilities of beractant and a synthetic peptide containing surfactant KL4. Pediatr Res 1996; 39: 947-52
75. Mbagwu N, Bruni R, Hernandez-Juviel JM, et al. Sensitivity of synthetic surfactants to albumin inhibition in preterm rabbits. Mol Genet Metab 1999; 66: 40-8
76. Seeger W, Thede C, Gunther A, et al. Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro: comparison to natural surfactant. Biochim Biophys Acta 1991; 1081: 45-52
77. al-Mateen KB, Dailey K, Grimes MM, et al. Improved oxygenation with exogenous surfactant administration in experimental meconium aspiration syndrome. Pediatr Pulmonol 1994; 17: 75-80
78. Calkovska A, Sun B, Curstedt T, et al. Combined effects of high-frequency ventilation and surfactant treatment in experimental meconium aspiration syndrome. Acta Anaesthesiol Scand 1999; 43: 135-45
79. Hilgendorff A, Rawer D, Doerner M, et al. Synthetic and natural surfactant differentially modulate inflammation after meconium aspiration. Intensive Care Med 2003; 29: 2247-54
80. Hu X, Cao L, Lam LK, et al. Mitigation of meconium-induced lung injury by surfactant and inhaled nitric oxide is associated with suppression of nuclear transcription factor kappa B. Biol Neonate 2004; 87: 73-81
81. Lyra JC, Mascaretti RS, Precioso AR, et al. Different doses of exogenous surfactant for treatment of meconium aspiration syndrome in newborn rabbits. Rev Hosp Clin Fac Med Sao Paulo 2004; 59: 104-12
82. Rais-Bahrami K, Rivera O, Seale WR, et al. Effect of nitric oxide in meconium aspiration syndrome after treatment with surfactant. Crit Care Med 1997; 25: 1744-7
83. Robinson TW, Roberts AM. Effects of exogenous surfactant on gas exchange and compliance in rabbits after meconium aspiration. Pediatr Pulmonol 2002; 33: 117-23
84. Sevecova-Mokra D, Calkovska A, Drgova A, et al. Treatment of experimental meconium aspiration syndrome with surfactant lung lavage and conventional vs asymmetric high-frequency jet ventilation. Pediatr Pulmonol 2004; 38: 285-91
85. Sun B, Curstedt T, Robertson B. Exogenous surfactant improves ventilation efficiency and alveolar expansion in rats with meconium aspiration. Am J Respir Crit Care Med 1996; 154: 764-70
86. Sun B, Curstedt T, Song GW, et al. Surfactant improves lung function and morphology in newborn rabbits with meconium aspiration. Biol Neonate 1993; 63: 96-104
87. Hudson ML, Louder DS, Stribley RF. Surfactant distribution in the piglet model of meconium aspiration [abstract]. Pediatr Res 1996; 39: 217A
88. Chappell SE, Wolfson MR, Shaffer TH. A comparison of surfactant delivery with conventional mechanical ventilation and partial liquid ventilation in meconium aspiration injury. Respir Med 2001; 95: 612-7
89. Segerer H, van Gelder W, Angenent FW, et al. Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by the instillation technique. Pediatr Res 1993; 34: 490-4
90. Segerer H, Scheid A, Wagner MH, et al. Rapid tracheal infusion of surfactant versus bolus instillation in rabbits: effects on oxygenation, blood pressure and surfactant distribution. Biol Neonate 1996; 69: 119-27
91. Auten RL, Notter RH, Kendig JW, et al. Surfactant treatment of full-term newborns with respiratory failure. Pediatrics 1991; 87: 101-7
92. Khammash H, Perlman M, Wojtulewicz J, et al. Surfactant therapy in full-term neonates with severe respiratory failure. Pediatrics 1993; 92: 135-9
93. Halliday HL, Speer CP, Robertson B. Treatment of severe meconium aspiration syndrome with porcine surfactant: Collaborative Surfactant Study Group. Eur J Pediatr 1996; 155: 1047-51
94. Blanke JG, Jorch G. Surfactant therapy in severe neonatal respiratory failure: multicenter study: II. Surfactant therapy in 10 newborn infants with meconium aspiration syndrome [in German]. Klin Pädiatr 1993; 205: 75-8
95. Lotze A, Knight GR, Martin GR, et al. Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation. J Pediatr 1993; 122: 261-8
96. Davis JM, Richter SE, Kendig JW, et al. High-frequency jet ventilation and surfactant treatment of newborns with severe respiratory failure. Pediatr Pulmonol 1992; 13: 108-12
97. Findlay RD, Taeusch HW, Walther FJ. Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 1996; 97: 48-52
98. Lotze A, Mitchell BR, Bulas DI, et al. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group. J Pediatr 1998; 132: 40-7
99. Soll RF, Dargaville P. Surfactant for meconium aspiration syndrome in full term infants. Cochrane Database Syst Rev 2000; (2): CD002054
100. Dargaville PA, Mills JF, Loughnan PM, et al. Large volume therapeutic pulmonary lavage in meconium aspiration syndrome [abstract]. Annual Scientific Meeting of the Royal Australian College of Physicians; 2002 May 6-8; Brisbane
101. Bhutani VK, Chima R, Sivieri EM. Innovative neonatal ventilation and meconium aspiration syndrome. Indian J Pediatr 2003; 70: 421-7
102. Wilson JM, Bower LK, Thompson JE, et al. ECMO in evolution: the impact of changing patient demographics and alternative therapies on ECMO. J Pediatr Surg 1996; 31: 1116-22
103. Hintz SR, Suttner DM, Sheehan AM, et al. Decreased use of neonatal extracorporeal membrane oxygenation (ECMO): how new treatment modalities have affected ECMO utilization. Pediatrics 2000; 106: 1339-43
104. Selecky PA, Wasserman K, Benfield JR, et al. The clinical and physiological effect of whole-lung lavage in pulmonary alveolar proteinosis: a ten-year experience. Ann Thorac Surg 1977; 24: 451-61
105. Wiswell TE, Smith RM, Katz LB, et al. Bronchopulmonary segmental lavage with Surfaxin (KL(4)-surfactant) for acute respiratory distress syndrome. Am J Respir Crit Care Med 1999; 160: 1188-95
106. Lober CW, Saltzman HA, Kylstra JA. Volume-controlled lung lavage in a woman with cystic fibrosis. Chest 1975; 68: 382-3
107. Ciravegna B, Sacco O, Moroni C, et al. Mineral oil lipoid pneumonia in a child with anoxic encephalopathy: treatment by whole lung lavage. Pediatr Pulmonol 1997; 23: 233-7
108. Burke-Strickland M, Edwards NB. Meconium aspiration in the newborn. Minn Med 1973; 56: 1031-5
109. Carson BS, Losey RW, Bowes WAJ, et al. Combined obstetric and pediatric approach to prevent meconium aspiration syndrome. Am J Obstet Gynecol 1976; 126: 712-5
110. Barrington KJ, Henderson CR, Cochrane CG, et al. Lung lavage with KL4 surfactant in a neonatal model of meconium aspiration: the importance of PEEP [abstract]. Pediatr Res 1998; 43: 166A
111. Foust R, Tran NN, Cox C, et al. Liquid assisted ventilation: an alternative ventilatory strategy for acute meconium aspiration injury. Pediatr Pulmonol 1996; 21: 316-22
112. Giuseppetti M, Wiswell TE. The use of saline lavage and surfactant therapy in the management of a piglet model of meconium aspiration syndrome [abstract]. Pediatr Res 1994; 35: 333A
113. Kuo CY, Hsueh C, Wang CR. Liquid ventilation for treatment of meconium aspiration syndrome in a piglet model. J Formos Med Assoc 1998; 97: 392-9
114. Lam BC, Yeung CY, Fu KH, et al. Surfactant tracheobronchial lavage for the management of a rabbit model of meconium aspiration syndrome. Biol Neonate 2000; 78: 129-38
115. Marraro G, Bonati M, Ferrari A, et al. Perfluorocarbon broncho-alveolar lavage and liquid ventilation versus saline broncho-alveolar lavage in adult guinea pig experimental model of meconium inhalation. Intensive Care Med 1998; 24: 501-8
116. Nakamura T, Matsuzawa S, Sugiura M, et al. A randomised control study of partial liquid ventilation after airway lavage with exogenous surfactant in a meconium aspiration syndrome animal model. Arch Dis Child Fetal Neonatal Ed 2000; 82: F160-2
117. Ohama Y, Itakura Y, Koyama N, et al. Effect of surfactant lavage in a rabbit model of meconium aspiration syndrome. Acta Paediatr Jpn 1994; 36: 236-8
118. Ohama Y, Ogawa Y. Treatment of meconium aspiration syndrome with surfactant lavage in an experimental rabbit model. Pediatr Pulmonol 1999; 28: 18-23
119. Paranka MS, Walsh WF, Stancombe BB. Surfactant lavage in a piglet model of meconium aspiration syndrome. Pediatr Res 1992; 31: 625-8
120. Schlösser RL, Veldman A, Fischer D, et al. Comparison of effects of perflubron and surfactant lung lavage on pulmonary gas exchange in a piglet model of meconium aspiration. Biol Neonate 2002; 81: 126-31
121. Sevecova D, Calkovska A, Drgova A, et al. Lung lavage using high-frequency jet ventilation in rabbits with meconium aspiration. Acta Paediatr 2003; 92: 314-9
122. Shaffer TH, Lowe CA, Bhutani VK, et al. Liquid ventilation: effects on pulmonary function in distressed meconium-stained lambs. Pediatr Res 1984; 18: 47-52
123. Tanveer A, Antunes MJ, Cleary GM, et al. Lung mechanics and inflammatory response in meconium injured rats following lung lavage with perfluorochemical or KL4 surfactant [abstract]. Pediatr Res 1998; 43: 299A
124. Ibara S, Ikenoue T, Murata Y, et al. Management of meconium aspiration syndrome by tracheobronchial lavage and replacement of Surfactant-TA. Acta Paediatr Jpn 1995; 37: 64-7
125. Kaneko M, Watanabe J, Ueno E. Surfactant lavage and replacement in meconium aspiration syndrome with pulmonary hemorrhage. J Perinat Med 2001; 29: 351-6
126. Mosca F, Colnaghi M, Castoldi F. Lung lavage with a saline volume similar to functional residual capacity followed by surfactant administration in newborns with severe meconium aspiration syndrome. Intensive Care Med 1996; 22: 1412-3
127. Su BH, Hu PS, Peng CT, et al. The effect of bronchial lavage and surfactant supplement on severe meconium aspiration syndrome. M Taiwan J Med 1998; 3: 191-7
128. Möller JC, Kohl M, Reiss I, et al. Saline lavage with substitution of bovine surfactant in term neonates with meconium aspiration syndrome (MAS) transferred for extracorporeal membrane oxygenation (ECMO): a pilot study. Crit Care (Lond) 1999; 3: 19-22
129. Kowalska K, Szymankiewicz M, Gadzinowski J. An effectiveness of surfactant lung lavage (SLL) in meconium aspiration syndrome (MAS) [in Polish]. Przegl Lek 2002; 59 Suppl. 1: 21-4
130. Lam BCC, Yeung CY. Surfactant lavage for meconium aspiration syndrome: a pilot study. Pediatrics 1999; 103: 1014-8
131. Salvia-Roiges MD, Carbonell-Estrany X, Figueras-Aloy J, et al. Efficacy of three treatment schedules in severe meconium aspiration syndrome. Acta Paediatr 2004; 93: 60-5
132. Szymankiewicz M, Gadzinowski J, Kowalska K. Pulmonary function after surfactant lung lavage followed by surfactant administration in infants with severe meconium aspiration syndrome. J Matern Fetal Neonatal Med 2004; 16: 125-30
133. Chang HY, Hsu CH, Kao HA, et al. Treatment of severe meconium aspiration syndrome with dilute surfactant lavage. J Formos Med Assoc 2003; 102: 326-30
134. Rosegger H, Engele H, Haas J. Tracheobronchial lavage: a supplementary measure in the initial management of meconium aspiration syndrome [in German]. Wien Klin Wochenschr 1987; 99: 843-7
135. Ogawa Y. Bronchial lavage with surfactant solution for the treatment of meconium aspiration syndrome. Hot Topics in Neonatology '97 Conference Proceedings. Columbus (OH): Professional Services Dept, Ross Products, 1997: 259-64
136. Wiswell TE, Knight GR, Finer NN, et al. A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics 2002; 109: 1081-7
137. Schlösser RL, Veldman A, Fischer D, et al. Lavage with exogenous surfactant in neonatal meconium aspiration syndrome [in German]. Z Geburtshilfe Neonatol 2002; 206: 15-8
138. Chesnutt MS, Nuckton TJ, Golden J, et al. Rapid alveolar epithelial fluid clearance following lung lavage in pulmonary alveolar proteinosis. Chest 2001; 120: 271-4
139. Bland RD. Loss of liquid from the lung lumen in labor: more than a simple "squeeze". Am J Physiol Lung Cell Mol Physiol 2001; 280: L602-5
140. Kattwinkel J. Surfactant lavage for meconium aspiration: a word of caution. Pediatrics 2002; 109: 1167-8
141. Kinsella JP. Meconium aspiration syndrome: is surfactant lavage the answer? Am J Respir Crit Care Med 2003; 168: 413-4
142. Discovery Laboratories. Product pipeline: SRT for respiratory medicine [online]. Available from URL: http://www.discovery labs.com/products-pipeline. htm [Accessed 2005 Sep 28]
143. Controlled trial of therapeutic lung lavage in meconium aspiration syndrome (the lessMAS trial) [online]. Available from URL: http://www.rch.org. au/neonatal_rch/lessmas [Accessed 2005 Sep 7]
144. Chinese Collaborative Study Group for Neonatal Respiratory Diseases. Treatment of severe meconium aspiration syndrome with porcine surfactant: a multicentre randomized controlled trial. Acta Paediatrica 2005; 94: 896-902